Watson/FDA Consent Decree Will Not Involve Product Recalls, Firm Says

Watson does not expect to recall any products manufactured at its Corona, Calif. facility as a result of a proposed consent decree with FDA, CEO Allen Chao, PhD, told analysts in a March 28 conference call

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet